Nichols & Pratt Advisers LLP Pfizer Inc Transaction History

Nichols & Pratt Advisers LLP

$1.5 Billion
Q3 2024

A detailed history of Nichols & Pratt Advisers LLP transactions in Pfizer Inc stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 52,133 shares of PFE stock, worth $1.39 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

52,133

Previous 52,133 -0.0%

Holding current value

$1.39 Million

Previous $1.46 Million 3.43%

% of portfolio

0.1%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $37,460 - $43,896	-1,483 Reduced 2.77%	52,133 $1.46 Million
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $5,203 - $5,975	-201 Reduced 0.37%	53,616 $1.49 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $32,793 - $42,594	-1,255 Reduced 2.28%	53,817 $1.55 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $109,747 - $128,284	-3,420 Reduced 5.85%	55,072 $1.83 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $9,030 - $10,447	-250 Reduced 0.43%	58,492 $2.15 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $9,020 - $11,743	-229 Reduced 0.39%	58,742 $2.4 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $158,190 - $206,500	3,789 Added 6.87%	58,971 $3.02 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $47,042 - $57,426	1,075 Added 1.99%	55,182 $2.42 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $196,270 - $290,937	-4,750 Reduced 8.07%	54,107 $3.2 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $1,962 - $2,521	-50 Reduced 0.08%	58,857 $2.53 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $24,849 - $28,025	742 Added 1.28%	58,907 $2.13 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $67,468 - $79,156	-2,125 Reduced 3.52%	58,165 $2.14 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $202,767 - $245,987	-6,732 Reduced 10.04%	60,290 $1.97 Million
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $270,678 - $386,740	10,014 Added 17.57%	67,022 $2.19 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $824,218 - $935,382	-25,037 Reduced 30.52%	57,008 $2.23 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $17,284 - $22,413	-532 Reduced 0.64%	82,045 $2.95 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $78,582 - $88,230	2,125 Added 2.64%	82,577 $3.58 Million
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $14,325 - $15,738	382 Added 0.48%	80,452 $3.42 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $215,970 - $246,230	-5,614 Reduced 6.55%	80,070 $3.5 Million
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $51,705 - $62,715	-1,500 Reduced 1.72%	85,684 $3.78 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $7,977 - $9,255	-250 Reduced 0.29%	87,184 $3.09 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $9,013 - $9,563	271 Added 0.31%	87,434 $3.17 Million
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $32,085 - $35,345	-1,035 Reduced 1.17%	87,163 $3.11 Million
Q2 2017 Aug 08, 2017	BUY	N/A	88,198	88,198 $2.96 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Account

Nichols & Pratt Advisers LLP Pfizer Inc Transaction History